Page last updated: 2024-10-27

gabexate and Coronary Disease

gabexate has been researched along with Coronary Disease in 2 studies

Gabexate: A serine proteinase inhibitor used therapeutically in the treatment of pancreatitis, disseminated intravascular coagulation (DIC), and as a regional anticoagulant for hemodialysis. The drug inhibits the hydrolytic effects of thrombin, plasmin, and kallikrein, but not of chymotrypsin and aprotinin.

Coronary Disease: An imbalance between myocardial functional requirements and the capacity of the CORONARY VESSELS to supply sufficient blood flow. It is a form of MYOCARDIAL ISCHEMIA (insufficient blood supply to the heart muscle) caused by a decreased capacity of the coronary vessels.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19901 (50.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ranucci, M1
Chihara, K1
Akiyama, F1
Shinozaki, T1
Shimamoto, M1
Takahashi, K1
Imura, H1
Yamazaki, F1
Kawarazaki, S1

Other Studies

2 other studies available for gabexate and Coronary Disease

ArticleYear
Gabexate mesilate and heparin responsiveness in coronary patients.
    Medical science monitor : international medical journal of experimental and clinical research, 2004, Volume: 10, Issue:3

    Topics: Aged; Antithrombins; Bleeding Time; Blood Coagulation; Coronary Disease; Factor Xa Inhibitors; Femal

2004
[Disseminated intravascular coagulation (DIC) following open heart surgery and great vessel surgery. The result of early administration of gabexate mesilate (FOY)].
    Kyobu geka. The Japanese journal of thoracic surgery, 1984, Volume: 37, Issue:8

    Topics: Adolescent; Adult; Aged; Blood Transfusion; Cardiac Surgical Procedures; Coronary Disease; Dissemina

1984